Investors find Mylan easy pill to swallow with juice

Capsules_230px
By Nigel Owen
17 May 2018

US pharmaceuticals company Mylan made its third visit to the euro corporate bond market in three years on Wednesday when it sold a €500m seven year deal with a €1.3bn order book.

Mylan sold a €3bn four-tranche deal in November 2016, but opted for a more modest €500m three year floating rate trade in May 2017, before sticking to the same size deal with a seven year fixed rate offering 12 months on.

Leads Deutsche Bank, JP ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.